Is RepliCel Life Sciences stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for RepliCel Life Sciences 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $0.200, you would have made a loss of $-0.157 per share or -78.50%
We do not have enough data to give you this answer.
RepliCel Life Sciences has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. RepliCel Life Sciences has a very good net profit margin of 113.02% and should have very high tolerances against inflation.
We have calculated the inflation risk for RepliCel Life Sciences to be medium [0.6 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.